{
  "docId": "019de076-05a8-756d-90c0-05335f3877b6",
  "docSlug": "06c66508aa113b26851e16e612e1d04c",
  "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides",
  "authorId": "mainz-biomed-nv",
  "authorName": "Mainz Biomed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 28,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 20,
  "notes": "The slide uses two scatter plots to compare diagnostic performance metrics against competitors like Guardant Health, Cologuard, and CellMax Life.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/19",
  "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6",
  "deckJsonHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6.json",
  "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.13,
        "y": 0.565
      },
      "kind": "callout",
      "text": "Most companies meet the expected 90% sensitivity and specificity for CRC",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37bb1288-95bb-4366-8b0d-3db92eda0487",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.73,
        "y": 0.17
      },
      "kind": "callout",
      "text": "Leading AA sensitivity by Mainz Biomed's mRNA powered test",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc009b16-b5a5-4e21-af44-1f6acc4f0d8c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.43,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "chart",
      "text": "CRC sensitivity scatter plot",
      "attrs": null,
      "subkind": "scatter",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d6f80b6-6147-4e51-8b36-8b0668a98fbd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.46,
        "x": 0.49,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Advanced Adenoma sensitivity scatter plot",
      "attrs": null,
      "subkind": "scatter",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a31241cd-a2a9-4c49-b52a-9598bf8ea2b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.15,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "* > 10,000 subjects screening studies",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f4bb20a-8e54-48f4-a0b9-1e333461da61",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Competition: CRC and Advanced Adenoma (AA) Sensitivity and Specificity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9dbde167-a0e3-438d-a7a9-e211b2b54de8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "898d9389-43bf-4f8f-94f1-6bf31a0991cb",
      "evidence": "Direct comparison of performance metrics against competitors",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 19,
      "from": 19,
      "beatId": "ddb86a32-9146-428c-9aba-e55500ab5892",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The document provides a competitive analysis on page 19",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 19,
      "name": "Mece Breakdown",
      "slug": "40-mece-breakdown",
      "bestFor": "Problem structuring, ensuring completeness, strategic analysis",
      "matchId": "35fffa56-7968-429c-bf10-755f823eda7c",
      "evidence": "The document presents a competitive analysis on page 19",
      "position": 1,
      "objective": "To provide a competitive analysis and demonstrate the advantages of Mainz Biomed's solution",
      "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage",
      "confidence": 0.6,
      "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}